Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Naldi

Showing results (11-20 of 289) with videos related to

Pageof 29
Sort By:
Dermatology (Basel, Switzerland)|August 16, 2003
Counting genetic skin disease in the populationLuigi Naldi
Dermatology (Basel, Switzerland)|March 24, 2005
A new era in the management of psoriasis? Promises and factsLuigi Naldi
Current Drug Targets. Inflammation and Allergy|June 8, 2004
Epidemiology of psoriasisLuigi Naldi
Lancet (London, England)|April 22, 2008
The search for effective and safe disease control in psoriasisLuigi Naldi
The Journal of Investigative Dermatology|January 24, 2017
Infections and Psoriasis Treatment: More "Real-World" Data Needed with Critical AppraisalLuigi Naldi
Recenti Progressi in Medicina|April 1, 2016
[Italy of miracles. Does the renaissaince of Italian science pass by the Vatican?]Luigi Naldi
BMJ Clinical Evidence|March 23, 2011
Seborrhoeic dermatitisLuigi Naldi
Drug Safety|April 22, 2008
Assessment of the risk of fragrance allergy in the general population: challenges and methodological issuesLuigi Naldi
Clinics in Dermatology|January 20, 2010
Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversiesLuigi Naldi
The British Journal of Dermatology|April 4, 2022
Going global with assessing the acne burden: is the evidence worth the effort?Luigi Naldi
Pageof 29

Showing results (11-20 of 289) with videos related to

Sort By:
Pageof 29
Dermatology (Basel, Switzerland)|August 16, 2003
Counting genetic skin disease in the populationLuigi Naldi
Dermatology (Basel, Switzerland)|March 24, 2005
A new era in the management of psoriasis? Promises and factsLuigi Naldi
Current Drug Targets. Inflammation and Allergy|June 8, 2004
Epidemiology of psoriasisLuigi Naldi
Lancet (London, England)|April 22, 2008
The search for effective and safe disease control in psoriasisLuigi Naldi
The Journal of Investigative Dermatology|January 24, 2017
Infections and Psoriasis Treatment: More "Real-World" Data Needed with Critical AppraisalLuigi Naldi
Recenti Progressi in Medicina|April 1, 2016
[Italy of miracles. Does the renaissaince of Italian science pass by the Vatican?]Luigi Naldi
BMJ Clinical Evidence|March 23, 2011
Seborrhoeic dermatitisLuigi Naldi
Drug Safety|April 22, 2008
Assessment of the risk of fragrance allergy in the general population: challenges and methodological issuesLuigi Naldi
Clinics in Dermatology|January 20, 2010
Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversiesLuigi Naldi
The British Journal of Dermatology|April 4, 2022
Going global with assessing the acne burden: is the evidence worth the effort?Luigi Naldi
Pageof 29